Imperva (NASDAQ:IMPV) had its target price boosted by Imperial Capital from $50.00 to $55.00 in a research report sent to investors on Friday morning. The brokerage currently has an outperform rating on the software maker’s stock.

A number of other brokerages have also recently issued reports on IMPV. Evercore ISI set a $56.00 price target on shares of Imperva and gave the stock a buy rating in a research note on Friday. Morgan Stanley upped their price target on shares of Imperva from $37.00 to $39.00 and gave the stock an underweight rating in a research note on Friday. Zacks Investment Research cut shares of Imperva from a buy rating to a hold rating in a research note on Wednesday, January 10th. Piper Jaffray Companies cut shares of Imperva from an overweight rating to a neutral rating and set a $42.00 price target on the stock. in a research note on Monday, October 16th. Finally, KeyCorp reiterated a hold rating on shares of Imperva in a research note on Tuesday, October 24th. Three analysts have rated the stock with a sell rating, five have issued a hold rating and eleven have issued a buy rating to the company’s stock. Imperva has an average rating of Hold and an average target price of $52.93.

Shares of Imperva (NASDAQ:IMPV) opened at $46.55 on Friday. The firm has a market cap of $1,580.00, a PE ratio of 69.48 and a beta of 1.79. Imperva has a 1 year low of $37.17 and a 1 year high of $52.40.

Imperva (NASDAQ:IMPV) last released its earnings results on Thursday, February 8th. The software maker reported $0.40 earnings per share for the quarter, topping the Zacks’ consensus estimate of $0.27 by $0.13. The firm had revenue of $91.10 million for the quarter, compared to the consensus estimate of $91.11 million. Imperva had a net margin of 7.11% and a negative return on equity of 3.37%. The company’s revenue was up 16.2% compared to the same quarter last year. During the same period in the prior year, the firm earned $0.32 EPS. analysts predict that Imperva will post -0.82 EPS for the current year.

Institutional investors and hedge funds have recently bought and sold shares of the business. New York State Common Retirement Fund lifted its stake in Imperva by 5.3% during the 2nd quarter. New York State Common Retirement Fund now owns 35,800 shares of the software maker’s stock valued at $1,713,000 after acquiring an additional 1,793 shares during the period. Prudential Financial Inc. increased its position in shares of Imperva by 80.7% during the 3rd quarter. Prudential Financial Inc. now owns 54,174 shares of the software maker’s stock valued at $2,351,000 after purchasing an additional 24,190 shares during the last quarter. Wells Fargo & Company MN increased its position in shares of Imperva by 11.9% during the 3rd quarter. Wells Fargo & Company MN now owns 213,953 shares of the software maker’s stock valued at $9,285,000 after purchasing an additional 22,741 shares during the last quarter. American Century Companies Inc. purchased a new stake in shares of Imperva during the 3rd quarter valued at about $6,832,000. Finally, Allianz Asset Management GmbH increased its position in shares of Imperva by 58.1% during the 3rd quarter. Allianz Asset Management GmbH now owns 59,149 shares of the software maker’s stock valued at $2,567,000 after purchasing an additional 21,732 shares during the last quarter. Institutional investors and hedge funds own 96.61% of the company’s stock.

ILLEGAL ACTIVITY WARNING: This report was originally reported by Daily Political and is the property of of Daily Political. If you are viewing this report on another site, it was copied illegally and republished in violation of US and international trademark & copyright laws. The correct version of this report can be viewed at https://www.dailypolitical.com/2018/02/12/imperial-capital-boosts-imperva-impv-price-target-to-55-00.html.

Imperva Company Profile

Imperva, Inc provides cyber-security solutions that protect business-critical data and applications whether in the cloud or on premises. The Company is engaged in the development, marketing, sales, service and support of cyber-security solutions. The Company’s products include its Imperva SecureSphere Paltform, Imperva CounterBreach and Imperva Camouflage for enterprise data centers, and Imperva Incapsula offering for cloud-based security services.

Analyst Recommendations for Imperva (NASDAQ:IMPV)

Receive News & Ratings for Imperva Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Imperva and related companies with MarketBeat.com's FREE daily email newsletter.